Legal & General Gbl Health & Pharmaceutical Idx Tst (I) Acc NAV

IMA Sector:

Specialist

ISIN:

GB00B0CNH387

Fund Type:

OEIC

121.20p
   
  • PEP:
  • ISA:
  • CAT Std:
  • Date: 20-Aug-2025
  • Change: 1.30p
  • Change %: 1.08%
  • Currency: GBP
  • YTD change: -7.90p
  • YTD %: -6.12%

Fund Objective

To provide the potential for reliable growth by tracking the performance of those companies in the FTSE World Index which are engaged in Health, Pharmaceuticals and Biotechnology.

Fund Performance

FTSE 100 FTSE 100 Fund Fund
5 year Legal & General Gbl Health & Pharmaceutical Idx Tst (I) Acc NAV
3 year Legal & General Gbl Health & Pharmaceutical Idx Tst (I) Acc NAV
1 Year Legal & General Gbl Health & Pharmaceutical Idx Tst (I) Acc NAV
6 Month Legal & General Gbl Health & Pharmaceutical Idx Tst (I) Acc NAV
1 Month Legal & General Gbl Health & Pharmaceutical Idx Tst (I) Acc NAV

Top 10 Holdings

Name % Net Assets
Johnson & Johnson 8.4%
Pfizer Inc. 5.4%
Roche Holding AG 5.1%
GlaxoSmithKline PLC 4.9%
Novartis 4.9%
Pfizer 3.9%
AstraZeneca PLC 3.4%
Wyeth 3.3%
Merck & Co., Inc 3.2%
Sanofi-Aventis 3.1%

Holdings Breakdown

Holding Chart
Key % Net Assets
Johnson & Johnson 8.4%
Pfizer Inc. 5.4%
Roche Holding AG 5.1%
GlaxoSmithKline PLC 4.9%
Other 76.2%

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Forecast figures based on normalised accounts.

 

Price Info

Date 20-Aug-2025
NAV 121.20p
Currency GBP
Change 1.30p
% 1.08%
YTD change -7.90p
YTD % -6.12%

Fund Facts

Fund Inception 01/11/2000
Fund Manager Ali Toutounchi
TER 0.31 (31-Dec-2013)

Fund Reports

Minimum Investment
Initial n/a
Additional n/a
Savings n/a
Charges
Initial n/a
Annual Mang't 0.30%
Exit n/a

Risks

Name %
Standard deviation 0.01
Sharpe ratio -0.07

Top of Page